Aardvark Therapeutics Statistics

Total Valuation

AARD has a market cap or net worth of $295.25 million. The enterprise value is $169.44 million.

Market Cap	295.25M
Enterprise Value	169.44M

Important Dates

The last earnings date was Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

AARD has 21.77 million shares outstanding. The number of shares has increased by 282.40% in one year.

Current Share Class	21.77M
Shares Outstanding	21.77M
Shares Change (YoY)	+282.40%
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	14.69%
Owned by Institutions (%)	19.38%
Float	11.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.41
P/TBV Ratio	2.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.03, with a Debt / Equity ratio of 0.00.

Current Ratio	12.03
Quick Ratio	11.77
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -48.06% and return on invested capital (ROIC) is -32.70%.

Return on Equity (ROE)	-48.06%
Return on Assets (ROA)	-30.81%
Return on Invested Capital (ROIC)	-32.70%
Return on Capital Employed (ROCE)	-43.65%
Revenue Per Employee	n/a
Profits Per Employee	-$2.22M
Employee Count	22
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	12.04
200-Day Moving Average	11.04
Relative Strength Index (RSI)	66.67
Average Volume (20 Days)	178,684

Short Selling Information

The latest short interest is 1.10 million, so 5.05% of the outstanding shares have been sold short.

Short Interest	1.10M
Short Previous Month	841,978
Short % of Shares Out	5.05%
Short % of Float	9.89%
Short Ratio (days to cover)	6.79

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-53.47M
Pretax Income	-48.77M
Net Income	-48.77M
EBITDA	-53.44M
EBIT	-53.47M
Earnings Per Share (EPS)	-$3.21

Full Income Statement

Balance Sheet

The company has $126.35 million in cash and $545,000 in debt, giving a net cash position of $125.81 million or $5.78 per share.

Cash & Cash Equivalents	126.35M
Total Debt	545,000
Net Cash	125.81M
Net Cash Per Share	$5.78
Equity (Book Value)	122.38M
Book Value Per Share	5.63
Working Capital	118.47M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$45.09 million and capital expenditures -$101,000, giving a free cash flow of -$45.19 million.

Operating Cash Flow	-45.09M
Capital Expenditures	-101,000
Free Cash Flow	-45.19M
FCF Per Share	-$2.08

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AARD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-282.40%
Shareholder Yield	-282.40%
Earnings Yield	-16.52%
FCF Yield	-15.31%

Analyst Forecast

The average price target for AARD is $30.63, which is 125.89% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$30.63
Price Target Difference	125.89%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1